Using probiotics to treat abdominal pain in children
Official title: The Effects of Probiotics, Lactobacillus GG, in the Treatment of Abdominal Pain in Children With Functional Abdominal Pain Disorders - A Randomized Controlled Trial
Run by Prince of Songkla University · NCT06310733 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study is testing if a probiotic called Lactobacillus GG can help children aged 6-15 with stomach pain feel better and improve their quality of life.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 6 Years to 15 Years |
| Sex | All |
| Enrollment | 54 (estimated) |
| Sponsor | Prince of Songkla University Academic / other |
| Locations | 1 site (Songkhla) |
| Trial ID | NCT06310733 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are children aged 6-15 diagnosed with irritable bowel syndrome or functional abdominal pain according to the Rome IV criteria.
✕Probably not a fit
Patients with chronic diseases, recent antibiotic or probiotic use, or those showing alarming signs of organic conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the effects of Lactobacillus GG, a type of probiotic, on children aged 6-15 who suffer from functional abdominal pain disorders, such as irritable bowel syndrome. The study aims to determine whether this probiotic can alleviate symptoms and improve the quality of life for these children. Participants will be divided into two groups, receiving either the probiotic or a placebo, to assess the effectiveness of the treatment. The trial is designed to provide insights into the role of the microbiome in managing abdominal pain in pediatric patients.
Why it matters
Potential benefit: If successful, this treatment could significantly reduce abdominal pain and improve the quality of life for children suffering from functional abdominal pain disorders.
How similar studies have gone: Previous studies have shown promising results with probiotics in managing gastrointestinal symptoms, suggesting potential success for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Children, aged 6-15 years old, with a diagnosis of IBS or FAP, according to the Rome IV diagnostic criteria. The diagnosis of IBS or FAP was based on a clinical interview performed by pediatric gastroenterologist. For healthy controls: non-obese children, aged 6-15 years old, without any gastrointestinal symptoms at the time of recruitment. Exclusion Criteria: * Children who 1. had any chronic diseases, including neurobehavioral disorders 2. received treatment with antibiotics/probiotics in the previous 2 months 3. received medication that affects gastrointestinal motility in the previous 1 week 4. had a pain history suggestive of functional dyspepsia/aerophagia/abdominal migraine/functional constipation 5. exhibited growth failure 6. had gastrointestinal obstructions/stricture 7. displayed alarming signs of organic condition 8. had previous abdominal surgery 9. had abnormal baseline test results as part of their standard work-up (e.g. complete blood counts; erythrocyte sedimentation rate; liver-pancreas-kidney function tests; stool examination for occult blood, ova, and parasites; fecal calprotectin; urinalysis; abdominal ultrasound; 13C-urea breath test; gastric emptying study, if any) 10. had family history of peptic ulcer disease or inflammatory bowel disease
Where it's running
-
Atchariya Chanpong
Songkhla, Thailand Recruiting
Study contacts
- Study coordinator: Atchariya Chanpong, M.D, Ph.D.
- Email: atchariya.c@psu.ac.th
- Phone: 6674451250
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Digital psychological treatment for children's abdominal pain
This study is testing two digital treatments for kids aged 8-14 with tummy pain to see which one helps them feel better.
-
Research on gut inflammation in pediatric patients with inflammatory bowel diseases
This study is trying to learn more about gut inflammation in kids with inflammatory bowel diseases by collecting health information and samples from them and comparing it to kids who have different gut issues but no inflammation.
-
Understanding how the brain processes chronic pain in children
This study is trying to understand how children's brains handle chronic pain from conditions like migraines and fibromyalgia to see what helps them recover.
-
Guided imagery therapy app for kids with functional abdominal pain
This study tests a guided imagery therapy app to see if it helps school-age children with functional abdominal pain disorders.
-
Understanding pain processing in adolescents with chronic pain conditions
This study looks at how teenagers with ongoing pain conditions feel and process pain differently than those with specific pain or healthy teens to better understand what might cause their pain.
-
Internet-delivered gut-directed hypnotherapy versus iCBT for stomach pain in children and teens
This trial will test whether online gut-directed hypnotherapy or internet-based cognitive behavioral therapy helps children and adolescents (8–17) with IBS, functional abdominal pain, or functional dyspepsia reduce stomach pain and improve daily life.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.